GIP, incretin and gastrointestinal disease.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002446:Celiac Disease / Q000378:metabolism; D004064:Digestive System / Q000187:drug effects*; D004381:Duodenal Ulcer / Q000378:metabolism; D005749:Gastric Inhibitory Polypeptide / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D005767:Gastrointestinal Diseases / Q000378:metabolism*; D005768:Gastrointestinal Hormones / Q000502:physiology*; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D004763:Glucagon-Like Peptides; D005951:Glucose Tolerance Test; D006801:Humans; D007082:Ileum / Q000601:surgery; D007328:Insulin / Q000378:metabolism; D007421:Intestine, Small / Q000601:surgery; D007515:Islets of Langerhans / Q000166:cytology; D007583:Jejunum / Q000601:surgery; D010446:Peptide Fragments / Q000502:physiology*; D010455:Peptides; D014628:Vagotomy
D001786:Blood Glucose; D005768:Gastrointestinal Hormones; D007328:Insulin; D010446:Peptide Fragments; D010455:Peptides; C055453:glucagon-like peptide 1 (7-36)amide; D005749:Gastric Inhibitory Polypeptide; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D005934:Glucagon